Who founded Corinnova?

Corinnova was founded by John Criscione.

Who are Corinnova's investors?

Corinnova's investors include Houston Angel Network, Keiretsu Forum, TMC Venture Fund, Cowtown Angels, Harvard Business School Alumni Angels of Greater New York, Wellcome Trust, Aggie Angel Network, Frontera Technology Ventures.

How much funding has Corinnova raised?

Corinnova has disclosed $350K raised across 1 round.

Where is Corinnova headquartered?

Corinnova is headquartered in Houston, US.

Corinnova

Houston, US · Texas corporation · 8 known investors

CorInnova develops a minimally invasive, non-blood contacting cardiac assist device designed to treat acute heart failure patients who cannot use existing solutions. The collapsible device is delivered via minimally invasive procedures and compresses the heart externally to increase cardiac output without the risks of blood clotting, stroke, or anticoagulation-related complications.

Deep Tech Healthtech Medical Devices

Founders & leadership

John CriscioneinFounder

William AltmaninExecutive

Dennis RobinsNamed on SEC filing

Boris LeschinskyNamed on SEC filing

Clarice MotterNamed on SEC filing

Keith SvagerkoNamed on SEC filing

Michael TinerNamed on SEC filing

Board

George LetsouinSenior Surgical Advisor

Investors · 8

Houston Angel Network✓ verifiedHouston

Keiretsu Forum✓ verifiedSan Francisco · $250K – $2M

TMC Venture Fund✓ verifiedHouston

Cowtown Angels✓ verifiedFort Worth

Harvard Business School Alumni Angels of Greater New York✓ verifiedNew York

Wellcome Trust✓ verifiedLondon

Aggie Angel NetworkCollege Station

Frontera Technology VenturesTexas

Reported raises · per SEC filings

Form D private placements

$350K disclosed across 1 round · 2017

▶$350KraisedJul 2017 · 3 investors · Other Health Care

Rule 506(b)

Officers, directors & promoters on the filing

John CriscioneDirector
Dennis RobinsDirector
Boris LeschinskyExecutive Officer
Clarice MotterExecutive Officer
Keith SvagerkoExecutive Officer
William AltmanExecutive Officer, Director
Michael TinerDirector

Offering amount: $8.8M
Amount sold: $350K
Minimum investment: $25K
Proceeds to insiders: $1.3M
First sale: Jun 2017
Incorporated: Corporation, Texas
Federal exemptions: 06b

Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Competitors · 5

by search overlap

Rf Surgical15 shared keywordsMedtronic is a healthcare technology company that develops medical devices and technologies — including pacemakers, robotic-assisted surgery systems, and AI-driven health tools — used by doctors, scientists, and engineers to treat pain and disease. It works with clinicians to create solutions aimed at treating conditions such as AFib.

Corwave14 shared keywordsCorWave produces a ventricular assist pump for advanced heart failure patients, delivering pulsatile flow to provide mechanical cardiac support for transplant candidates, non-transplant-eligible patients, and recovery cases.

Topera12 shared keywordsAbbott's Lingo Glucose System is a continuous glucose monitoring device for non-insulin users aged 18+, designed to track glucose levels and support metabolic health decisions.

Ancora Heart11 shared keywordsAncora Heart develops minimally invasive medical devices, including a class III implantable therapy for cardiovascular treatment. The company focuses on cardiac/heart failure therapy development, clinical research, and commercialization of its core technology.

Bioworld10 shared keywordsBioWorld is a suite of daily news and data services covering therapeutics, medical technology, biopharma business transactions, and drug R&D, serving biopharmaceutical and medtech industry professionals. Owned by Clarivate, it publishes products including BioWorld, BioWorld Science, and BioWorld Asia with reporting from writers stationed globally.

Companies competing with Corinnova for the same Google search keywords, organic and paid, via search-intersection analysis.

Frequently asked questions

What does Corinnova do?: CorInnova develops a minimally invasive, non-blood contacting cardiac assist device designed to treat acute heart failure patients who cannot use existing solutions. The collapsible device is delivered via minimally invasive procedures and compresses the heart externally to increase cardiac output without the risks of blood clotting, stroke, or anticoagulation-related complications.
Who founded Corinnova?: Corinnova was founded by John Criscione.
Who are Corinnova's investors?: Corinnova's investors include Houston Angel Network, Keiretsu Forum, TMC Venture Fund, Cowtown Angels, Harvard Business School Alumni Angels of Greater New York, Wellcome Trust, Aggie Angel Network, Frontera Technology Ventures.
How much funding has Corinnova raised?: Corinnova has disclosed $350K raised across 1 round.
Where is Corinnova headquartered?: Corinnova is headquartered in Houston, US.